OptimizeRx (OPRX) Short term Debt (2019 - 2026)

OptimizeRx's Short term Debt history runs 6 years deep, the most recent figure standing at $2.0 million for Q1 2026.

• In Q1 2026, Short term Debt fell 39.39% year-over-year to $2.0 million; the TTM figure through Mar 2026 stood at $2.0 million (down 39.39% YoY), while the FY2025 annual figure was $4.3 million, up 112.75% from the prior year.
• Short term Debt came in at $2.0 million for Q1 2026 at OptimizeRx, down from $4.3 million in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $4.3 million in Q4 2025 to a low of $2.0 million in Q4 2023.
• A 4-year average of $2.9 million and a median of $3.3 million in 2024 frame the typical range for Short term Debt.
• Across the five-year window, Short term Debt surged 112.75% in 2025 and tumbled 39.39% in 2026, its largest moves.
• OptimizeRx's Short term Debt stood at $2.0 million in 2023, then changed by 0.0% to $2.0 million in 2024, then soared by 112.75% to $4.3 million in 2025, then tumbled by 53.0% to $2.0 million in 2026.
• According to Business Quant data, Short term Debt over the past three periods registered $2.0 million, $4.3 million, and $3.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison